Sampling times and genotyping concerns in bioequivalence evaluation of branded and generic formulations.
作者信息
Zhao Xiao-Ying, Xu Hui-Min, Zhou Quan
机构信息
The Medical Ethics Committee, Zhejiang University, Hangzhou, Zhejiang Province, People's Republic of China.
Department of Pharmacy, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, People's Republic of China.
出版信息
Ther Clin Risk Manag. 2013;9:463-8. doi: 10.2147/TCRM.S54607. Epub 2013 Nov 25.
Abstract
摘要
相似文献
1
Sampling times and genotyping concerns in bioequivalence evaluation of branded and generic formulations.
Ther Clin Risk Manag. 2013;9:463-8. doi: 10.2147/TCRM.S54607. Epub 2013 Nov 25.
2
Lack of pharmacokinetic bioequivalence between generic and branded amoxicillin formulations. A post-marketing clinical study on healthy volunteers.
Br J Clin Pharmacol. 2009 Jul;68(1):34-42. doi: 10.1111/j.1365-2125.2009.03399.x.
3
Bioavailability and pharmacokinetic comparison between generic and branded azithromycin capsule: a randomized, double-blind, 2-way crossover in healthy male Thai volunteers.
Clin Ther. 2007 Apr;29(4):703-10. doi: 10.1016/j.clinthera.2007.04.010.
4
Bioequivalence of Branded and Generic Oxaliplatin: From Preclinical Assessment to Clinical Incidence of Hypersensitivity Reactions.
Anticancer Res. 2016 Oct;36(10):5163-5170. doi: 10.21873/anticanres.11086.
5
Is generic rifaximin still a poorly absorbed antibiotic? A comparison of branded and generic formulations in healthy volunteers.
Pharmacol Res. 2014 Jul;85:39-44. doi: 10.1016/j.phrs.2014.05.001. Epub 2014 May 14.
6
Comparative pharmacokinetic and pharmacodynamic evaluation of branded and generic formulations of meloxicam in healthy male volunteers.
Ther Clin Risk Manag. 2013;9:303-11. doi: 10.2147/TCRM.S39024. Epub 2013 Jul 24.
7
Rational use of generic psychotropic drugs.
CNS Drugs. 2013 May;27(5):353-65. doi: 10.1007/s40263-013-0045-2.
8
In Vitro Dissolution and In Vivo Bioequivalence Evaluation of Two Metformin Extended-Release Tablets.
Clin Pharmacol Drug Dev. 2021 Apr;10(4):414-419. doi: 10.1002/cpdd.857. Epub 2020 Jul 24.
9
Differences between the quality aspects of various generic and branded docetaxel formulations.
Curr Med Res Opin. 2021 Aug;37(8):1421-1433. doi: 10.1080/03007995.2021.1929895. Epub 2021 Jun 7.
10
Sodium ferric gluconate (SFG) in complex with sucrose for IV infusion: bioequivalence of a new generic product with the branded product in healthy volunteers.
Curr Med Res Opin. 2011 Aug;27(8):1653-7. doi: 10.1185/03007995.2011.597738. Epub 2011 Jun 30.
引用本文的文献
1
Views and perceptions about locally manufactured medicines in Ethiopia: a qualitative study of physicians, patients and regulatory authorities.
BMC Health Serv Res. 2018 Aug 8;18(1):624. doi: 10.1186/s12913-018-3410-5.
2
The use of oral suspension and rationally prescribing alternatives may be supplemental to the implementation of clopidogrel new algorithm comprising CYP2C19 pharmacogenetics and drug interactions.
Ther Clin Risk Manag. 2016 Mar 2;12:351-2. doi: 10.2147/TCRM.S103196. eCollection 2016.
本文引用的文献
1
Comparative pharmacokinetic and pharmacodynamic evaluation of branded and generic formulations of meloxicam in healthy male volunteers.
Ther Clin Risk Manag. 2013;9:303-11. doi: 10.2147/TCRM.S39024. Epub 2013 Jul 24.
2
3
CYP2C9 polymorphism analysis in Han Chinese populations: building the largest allele frequency database.
Pharmacogenomics J. 2014 Feb;14(1):85-92. doi: 10.1038/tpj.2013.2. Epub 2013 Feb 12.
4
Pharmacokinetics and bioavailability comparison of generic and branded citalopram 20 mg tablets: an open-label, randomized-sequence, two-period crossover study in healthy Chinese CYP2C19 extensive metabolizers.
Clin Drug Investig. 2013 Jan;33(1):1-9. doi: 10.1007/s40261-012-0010-8.
5
Use of pharmacogenetics in bioequivalence studies to reduce sample size: an example with mirtazapine and CYP2D6.
Pharmacogenomics J. 2013 Oct;13(5):452-5. doi: 10.1038/tpj.2012.29. Epub 2012 Jun 26.
6
Bioequivalence study of two brands of meloxicam tablets in healthy human Pakistani male subjects.
Acta Pol Pharm. 2011 Jan-Feb;68(1):115-9.
7
The new European Medicines Agency guideline on the investigation of bioequivalence.
Basic Clin Pharmacol Toxicol. 2010 Mar;106(3):221-5. doi: 10.1111/j.1742-7843.2009.00518.x. Epub 2010 Jan 7.
8
CYP3A5*3 genotype associated with intrasubject pharmacokinetic variation toward tacrolimus in bioequivalence study.
Ther Drug Monit. 2010 Feb;32(1):67-72. doi: 10.1097/FTD.0b013e3181c49a4c.
9
Bioequivalence study of two meloxicam tablet formulations after single-dose administration in healthy Thai male volunteers.
Int J Clin Pharmacol Ther. 2009 Oct;47(10):638-42. doi: 10.5414/cpp47638.
10
Bioequivalence studies of two brands of meloxicam tablets in healthy Pakistani volunteers.
Pak J Pharm Sci. 2009 Apr;22(2):199-204.
Zotero 插件